15/06/2021 European Alzheimer’s Disease Consortium (EADC) responds to FDA approval of aducanumab Science watch
15/06/2021 The AI-Mind project invites healthcare professionals to participate in a survey on clinical practices related to mild cognitive impairment EU projects
14/06/2021 Alzheimer Europe online Annual General Meeting adopts new Strategic Plan 2021-2025 Alzheimer Europe
14/06/2021 Results of Phase II ADAMANT trial of AADVac1 for mild Alzheimer's disease published in Nature Aging Science watch
11/06/2021 NEURONET hosts meetings of its Patient Privacy & Ethics and Data Sharing working groups EU projects
11/06/2021 Petri Lampinen, member of the European Working Group of People with Dementia, manages to overcome the limitations imposed by COVID Living with dementia
08/06/2021 Alzheimer Europe contributes to paper on “Dementia and COVID-19, a Bidirectional Liaison: Risk Factors, Biomarkers, and Optimal Health Care” Alzheimer Europe
08/06/2021 Anavex completes enrolment of its Phase II/III clinical trial in people with Alzheimer’s disease Science watch
07/06/2021 FDA approves aducanumab, a first disease-modifying treatment for Alzheimer's disease Science watch
